Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanara MedTech Inc. Director's Dealing 2023

Jun 6, 2023

33339_dirs_2023-06-05_fd998c35-3e46-4993-96f3-d85a86ad77c2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2023-06-01

Reporting Person: STUCKERT JAMES W (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-06-01 Common Stock A 2802 Acquired 836778 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 10000 Indirect
Common Stock 46500 Indirect
Common Stock 70254 Indirect

Footnotes

F1: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the earlier of (i) the date of the 2024 annual shareholder meeting or (ii) June 1, 2024, provided that the reporting person is providing certain services to the Company on such date.

F2: The reporting person is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F3: The reporting person serves as the general partner of the partnership.